C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The target demographic will be those between the ages of 30 and 65 years
Subscribe To Our Newsletter & Stay Updated